Effects of anti-Leishmania monoclonal antibodies on the development of Leishmania major in Phlebotomus duboscqi (Diptera: Psychodidae)

East African Medical Journal

Volumn 83, Issue 2, 2006, Pages 72-78

  Anjili, C ^a   Langat, B ^a   Ngumbi, P ^a   Mbati, P A ^b   Githure, J ^c   Tonui, W K ^a  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b UNIVERSITY OF LIMPOPO   (South Africa)

^c INTERNATIONAL CENTRE OF INSECT PHYSIOLOGY AND ECOLOGY ICIPE   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; PROTOZOON ANTIBODY;

ANIMAL; ANTIBODY PRODUCTION; ARTICLE; BAGG ALBINO MOUSE; DISEASE CARRIER; DRUG EFFECT; FEMALE; IMMUNOLOGY; ISOLATION AND PURIFICATION; KENYA; LEISHMANIA MAJOR; MOUSE; PARASITOLOGY; PHLEBOTOMUS; SKIN LEISHMANIASIS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, PROTOZOAN; ANTIBODY FORMATION; FEMALE; INSECT VECTORS; KENYA; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED BALB C; PHLEBOTOMUS;

EID: 33646473426     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Muigai, R., Githure, J.I., Gachihi, G., et al. Cutaneous leishmaniasis caused by Leishmania major in Baringo District, Kenya. Trans. R. Soc. Trop. Med, Hyg. 1987; 81: 600-602.
2. Beach, R., Kiilu, G., Hendricks, L.D., et al. Cutaneous leishmaniasis: transmission of Leishmania major to man by the bite of naturally infected Phlebotomus duboscqi. Trans. R. Soc. Trop. Med. and Hyg. 1984; 78: 747-751.
3. Ngumbi P.M., Irungu, L.W., Robert, L.L., et al. Abundance and nocturnal activities of phlebotomine sand flies (Diptera: Psychodidae) in termite hills and animal burrows in Baringo district Kenya. Afr. J. Health Sci. 1998; 5: 28-34.
4. Githure, J.I., Schnur, L.F., Blancq, S.M. et al. Characterization of Kenyan Leishmania spp. and identification of Mastomys natalensis, Tarterillus emini and Aethomys kaiseri as new hosts of L. major. Ann. Trop. Med and Parasitol. 1986; 80: 501-507.
5. Modabber, F. Experiences with vaccines against cutaneous leishmaniasis: of men and mice. Parasitol. 1989; 98: S49-S60.
6. Kaul, S.M., Wattal, B.L., Bhatnagar, U.N., et al. Preliminary observations on the susceptibility status of Phlebotomus argentipes and Phlebotomus papatasi to DDT in two districts of northern Bihar (India). J. Commun. Dis. 1978; 10: 208-211.
7. Tesh, R.B., Woan, R.U., and Cataccio, D. Survival of albumin, IgG, 1gM and complement (C3) in human blood after ingestion by Aedes albopictus and Phlebotomus papatasi. Amer. J. Trop. Med. Hyg. 1988; 39: 127-130.
8. Mbati, P.A., Anjili, C.O., Odongo, S., et al. Leishniania major infections in Phlebotomus duboscqi fed on murine models immunised with L. major subcellular antigens and sand fly gut antigens. Onderstepoort J. Vet, Res. 2000; 67: 57-63.
9. Tonui W.K. Anjili C.O., Orago A.S., et al. Transmission blocking vaccine studies in leishmaniasis: 1. Lipophosphoglycan is a promising transmission blocking vaccine molecule against cutaneous leishmaniasis. East Afr. Med. J. 2601a, 78: 84-89.
10. Ingonga, P., Mbati, P.A., Anjili, C.O., et al. The effect of immune sera from hamsters immunised with sand fly gut and whole body extract antigens on the fecundity and mortality of Phlebotomus duboscqi (Diptera: Psychodidae) Acta. Trop. 1996; 60: 269-279.
11. Tonui W.K., Anjili C.O., Orago A.S., et al. Transmission blocking vaccine studies in leishmaniasis: II. Effect of immunisation using Leishmania major derived 63 Kilodalton glycoprotein, lipophosphoglycan, and whole parasite antigens on the course of L. major infection in BALB/c mice. East Afr. Med. J. 201b; 78: 90-92.
12. Tonui W.K., Mpoke S.S., Orago A.S., et al. Leishmania major-Phlebotomus duboscqi interactions: inhibition of anti-LPG antibodies and characterisation of two proteins with shared epitopes. East Afr. Med. J. 2004; 81: 97-103.
13. Hendricks, L. and Wright, N. Diagnosis of cutaneous leishmaniasis by in vitro cultivation of saline aspirates in Schneider's Drosophila medium. Amer. J. Trop. Med. Hyg. 1979; 28: 962-964.
14. Kimber, C.D., Evans, D.A., Robinson, B.L., and Peters, W. Control of yeast contamination with 5-fluorocytocine in the in vitro cultivation of Leishmania spp. Annals Trop. Med. and Parasitol. 1981; 75: 453-454.
15. Beach, R., Young, D.G. and Kiilu, G. New Phlebotomine sand fly colonies II. Laboratory colonisation of Phlebotomus duboscqi (Diptera: Psychodidae). J. Med. Entomol. 1986; 23: 114-115.
16. Johnson, P.T., McConnell, E. and Hertig, M. Natural infections of leptomonad flagellates in Panamanian phlebotomine sand flies. Exp. Parasitol. 1963; 14: 107-122.
17. Chulay, J.D. and Brycesson, A.D.M. Quantitation of amastigote of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis. Amer. J. Trop. Med. Hyg. 1983; 32: 475-479.
18. Adler, S. Attempts to transmit visceral leishmaniasis to man. Trans. R. Soc. Trop. Med. Hyg. 1940; 34: 419.
19. Theodos, C.M., Ribeiro, J.M.C. and Titus, R.G. Analysis of enhancing effect of sandfly saliva on Leishmania infection in mice. Infect, and Immun. 1991; 59: 1592-1598.
20. Tolson, L., Turco, J., Robert, P., et al. The immunological structure and surface arrangement of Leishmania donovani lipophosphoglycan determined using monoclonal antibodies. Mol. Biochem. Parasitol. 1989; 35: 109-118.
21. Anderson, S. David, J.R., and McMahon-Pratt, D. In vivo protection against Leishmania mexicana mediated by monoclonal antibodies. J. Immunol. 1983; 131: 1616-1618.
22. Doherty, T.M. and Coffman, R.L. Leishmania major: Effect of infectious dose on T cell subset development in BALB/c mice. Exp. Parasitol. 1996; 84: 124-135.
23. Rachamin, N., and Jaffe, C.L. Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis. J. Immunol. 1993; 150: 2322-2331.
24. Gicheru, M.M., Olobo, J.O., and Anjili, C.O. Heterologous protection by Leishmania donovani for Leishmania major infections in the vervet monkey model of the disease. Exp. Parasitol. 1997; 85: 109-116.
25. Mauel, J., and Behin, R. Leishmaniasis immunity, immunopathology and immunodiagnosis. In: Immunity to Parasitic Infections" (S. Cohen, and K.S. Waren, Eds), 1982: 3443-3463. Blackwell Sie., Oxford.
26. Liew, F.Y. Functional heterogeneity of CD4+ T cells in leishmaniasis. Immunol. Today. 1989; 10: 40-45.
27. Herman, R. Cytophilic and opsonic antibodies in visceral leishmaniasis in mice. Infect. and Immun. 1980; 28: 585-593.
28. Pearson, R.D. and Steigbigel, R.T. Mechanism of lethal effect of human serum upon Leishmania donovani. J. Immunol. 1980; 125: 2195-2201.
29. Jaffe, C.L. and McMahon-Pratt, D. Monoclonal antibodies specific for Leishmania tropica. Characterisation of antigens associated with stage and species-specific determinants. J. Immunol., 1983; 131: 1987-1993.
30. Debons-Guillemin, M.C., Vouldoukis, I., Roseto, A., et al. Inhibition in vivo of both infective Leishmania major and L. mexicana amazonensis mediated by a single monoclonal antibody. Trans. R. Soc. Trop. Med. and Hyg. 1986; 80: 258-260.
31. Ramasamy, M.S. and Ramasamy, R. Effect of host anti-mosquito antibodies on mosquito physiology and mosquito-pathogen interactions. In: host regulated developmental mechanisms in vector arthropods. Proceedings of the second symposium, Vero Beach, Florida. Ed D. Borovsky and Spielman, 1989; 142-147.
32. Monjour, L., Vouldoukis, I., Debons-Guillemin, M.C., et al. Application of an in vivo culture system for rapid demonstration of anti-Leishmania activity of monoclonal antibodies. Trans. R. Soc. Trop. Med. and Hyg. 1987; 81: 210-211